Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic
Background: The pandemic has changed many aspects of healthcare, including the treatment of people with opioid use disorder with buprenorphine. Prior to the pandemic, rural health disparities existed in the accessibility of this treatment. Rural and frontier areas of the United States, particularly...
Main Author: | Lisa M. McFadden |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Drug and Alcohol Dependence Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772724623000252 |
Similar Items
-
Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018
by: Olivia K. Golan, et al.
Published: (2023-12-01) -
Patients' perspectives on buprenorphine subcutaneous implant: a case series
by: Claudio Pierlorenzi, et al.
Published: (2024-04-01) -
Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats
by: Venumadhav Janganati, et al.
Published: (2023-05-01) -
Adapting low-dose buprenorphine induction to meet patient needs: A pilot study
by: Zoe A. Karavolis, et al.
Published: (2022-12-01) -
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
by: Neil B. Patel, et al.
Published: (2024-01-01)